Jupiter Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,755
| Closed | -$421K | – | 435 |
|
|
2024
Q1 | $421K | Hold |
5,755
| – | – | ﹤0.01% | 396 |
|
|
2023
Q4 | $411K | Hold |
5,755
| – | – | ﹤0.01% | 419 |
|
|
2023
Q3 | $345K | Hold |
5,755
| – | – | ﹤0.01% | 449 |
|
|
2023
Q2 | $414K | Hold |
5,755
| – | – | ﹤0.01% | 465 |
|
|
2023
Q1 | $422K | Hold |
5,755
| – | – | 0.01% | 380 |
|
|
2022
Q4 | $384K | Sell |
5,755
-3,470
| -38% | -$231K | 0.01% | 419 |
|
|
2022
Q3 | $496K | Hold |
9,225
| – | – | 0.01% | 436 |
|
|
2022
Q2 | $512K | Sell |
9,225
-16,285
| -64% | -$904K | 0.01% | 487 |
|
|
2022
Q1 | $1.79M | Sell |
25,510
-467
| -2% | -$32.7K | 0.02% | 362 |
|
|
2021
Q4 | $2.53M | Sell |
25,977
-2,569
| -9% | -$250K | 0.03% | 326 |
|
|
2021
Q3 | $2.48M | Hold |
28,546
| – | – | 0.03% | 325 |
|
|
2021
Q2 | $2.33M | Hold |
28,546
| – | – | 0.02% | 377 |
|
|
2021
Q1 | $2.71M | Sell |
28,546
-18,749
| -40% | -$1.78M | 0.03% | 380 |
|
|
2020
Q4 | $2.93M | Buy |
+47,295
| New | +$2.93M | 0.03% | 384 |
|